| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRVL | Common Stock | Options Exercise | $149,073 | +1,700 | +28% | $87.69 | 7,680 | 20 Feb 2024 | Direct | |
| transaction | CRVL | Common Stock | Tax liability | $148,940 | -595 | -7.7% | $250.32 | 7,085 | 20 Feb 2024 | Direct | F1 |
| transaction | CRVL | Common Stock | Tax liability | $95,622 | -382 | -5.4% | $250.32 | 6,703 | 20 Feb 2024 | Direct | F1 |
| transaction | CRVL | Common Stock | Options Exercise | $131,535 | +1,500 | +22% | $87.69 | 8,203 | 21 Feb 2024 | Direct | |
| transaction | CRVL | Common Stock | Tax liability | $131,489 | -504 | -6.1% | $260.89 | 7,699 | 21 Feb 2024 | Direct | F1 |
| transaction | CRVL | Common Stock | Tax liability | $104,356 | -400 | -5.2% | $260.89 | 7,299 | 21 Feb 2024 | Direct | F1 |
| transaction | CRVL | Common Stock | Options Exercise | $34,817 | +438 | +6% | $79.49 | 7,737 | 21 Feb 2024 | Direct | |
| transaction | CRVL | Common Stock | Sale | $113,880 | -438 | -5.7% | $260.00 | 7,299 | 21 Feb 2024 | Direct | |
| transaction | CRVL | Common Stock | Options Exercise | $19,759 | +375 | +5.1% | $52.69 | 7,674 | 21 Feb 2024 | Direct | |
| transaction | CRVL | Common Stock | Sale | $97,500 | -375 | -4.9% | $260.00 | 7,299 | 21 Feb 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -375 | -94% | $0.000000 | 25 | 21 Feb 2024 | Common Stock | 375 | $52.69 | Direct | F2 |
| transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -438 | -88% | $0.000000 | 62 | 21 Feb 2024 | Common Stock | 438 | $79.49 | Direct | F2 |
| transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | $425,544 | -1,700 | -26% | $250.32 | 4,800 | 20 Feb 2024 | Common Stock | 1,700 | $87.69 | Direct | F3 |
| transaction | CRVL | Non-Qualified Stock Option (right to buy) | Options Exercise | $391,335 | -1,500 | -31% | $260.89 | 3,300 | 21 Feb 2024 | Common Stock | 1,500 | $87.69 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise. |
| F2 | Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| F3 | Option will vest based on achievement of certain performance criteria relating to earnings growth. |